Inspirna Strengthens Scientific Advisory Board with Two Globally Renowned Experts in Gastrointestinal Oncology
--Drs. Josep Tabernero, M.D., Ph.D. and Alan Venook, M.D. to Support Company in Advancing Pipeline of Novel Drug Candidates Derived from its RNA-DRIVErTM Discovery Platform NEW YORK--(BUSINESS WIRE)--Inspirna, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and biologic cancer therapeutics,